Boston Scientific announced today that it agreed to acquire Axonics (Nasdaq:AXNX) in a deal worth approximately $3.7 billion. Shares of AXNX skyrocketed before the market opened today, rising 21.1% to $69.72 apiece. Shares of BSX stayed even. Marlborough, Massachusetts-based Boston Scientific priced the acquisition at $71 in cash per share. It amounts to an equity […]
Mergers & Acquisitions
Align Technology acquires 3D printing company Cubicure
Align Technology (Nasdaq:ALGN) announced that it completed the acquisition of 3D printing company Cubicure. Cubicure offers 3D printing solutions for polymer additive manufacturing. It develops, produces and distributes innovative materials, equipment and processes for novel 3D printing solutions. Tempe, Arizona-based Align plans for the acquisition to support and scale its strategic innovation roadmap and strengthen […]
Enovis completes $846M LimaCorporate acquisition
Enovis (NYSE:ENOV) announced today that it closed its nearly $850 million acquisition of orthopedic company LimaCorporate. Wilmington, Delaware-based Enovis announced its intent to acquire Lima in September. Enovis — one of the 10 largest orthopedic companies in the world — valued the deal at approximately $846.4 million (€800 million). The deal includes a $740.6 million (€700 […]
The 10 biggest diabetes tech stories from 2023
It was another banner year for diabetes technology, with regulatory approvals, product launches and M&A all playing their part. Diabetes technology’s impressive 12 months marked a major trend across medtech as a whole, too. In 2022, the diabetes space saw plenty of progress from some of its biggest names and this past year proved no different. […]
The top medtech trends of 2023
The top medtech trends of 2023 included innovations such as artificial intelligence, new GLP-1 weight loss drugs and some long-awaited medtech finally receiving regulatory nods. With health providers facing additional challenges on top of an ever-uncertain economic environment, medtech companies also made major readjustments: layoffs, spinoffs, reorganizations and much more. Here are the top stories […]
Henry Schein enters orthopedic extremities market by acquiring majority interest in TriMed
Henry Schein announced today that it made a strategic move to enter the extremities segment of the orthopedic market. Melville, New York-based Henry Schein plans to enter into the upper and lower extremities market. To execute this strategy, the company signed an agreement to acquire a majority interest in TriMed. TriMed develops orthopedic solutions for […]
Illumina will divest Grail after court backs FTC ruling
Illumina (Nasdaq:ILMN) announced that it plans to divest Grail after a drawn-out legal battle over the $7.1 billion acquisition. In September 2020, Illumina announced an agreement to acquire Grail, a DNA sequencing and array-based tech developer. Grail itself was a startup that initially spun out from the company in 2016. Illumina completed the acquisition in […]
Stryker to acquire joint replacement company SERF SAS
Stryker announced today that it executed a binding offer to acquire SERF SAS, a France-based joint replacement company. The Kalamazoo, Michigan-based orthopedic giant executed the offer with Menix, a leader in the dual mobility and first intention stem markets in France. SERF SAS develops, manufactures and sells a range of large joint replacement products on […]
ZimVie to sell spine business, become pure-play dental company
ZimVie announced today that it agreed to sell its spine business to investment firm H.I.G. Capital. Shares of ZIMV skyrocketed more than 50% to $17.05 apiece by the afternoon. MassDevice‘s MedTech 100 Index was up slightly. The sale of the business, valued at $375 million, establishes ZimVie as a pure-play dental company. Westminster, Colorado-based ZimVie […]
Carl Zeiss Meditec enhances ophthalmic portfolio with $1B acquisition
Carl Zeiss Meditec announced today that it entered into an agreement to acquire 100% of the shares in Dutch Ophthalmic Research Center. The Germany-based company acquired DORC from the France-based investment firm Eurazeo. It expects the acquisition to enhance and complement its broad ophthalmic portfolio and range of digitally connected workflow solutions. The company develops […]
Integra LifeSciences to buy Johnson & Johnson’s Acclarent and its ENT tech
Integra LifeSciences announced today that it entered into a definitive agreement to acquire Acclarent from Johnson & Johnson MedTech. Acclarent, part of J&J MedTech’s Ethicon unit, enhances Integra’s position in the ear, nose and throat (ENT) treatment market. Integra already offers the MicroFrance line of ENT instruments. The company believes that, upon closing, the deal […]